| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.01 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |